research integrity, genetics & genomics

Current reporting about the contribution of genetic variations to a person’s risk of disease is often incomplete and hard to interpret, according to the authors of a set of best practices for presenting such information.

Criticism of the paper first surfaced in 1994, and its author was accused of scientific misconduct.

The agency is now evaluating the implications of the corrupted data behind Zolgensma and whether to “take action” against the pharmaceutical company.

A study estimates that 0.15 percent of genetics articles are retracted, most commonly for duplication and plagiarism.

An external consultant will review the work environment of the institution’s Australian Centre for Ancient DNA, led by evolutionary molecular biologist Alan Cooper.

An internal report finds Hikmet Budak touched students inappropriately and discriminated against them based on their country of origin, sex, marriage status, and other factors.

Certain populations have been historically underrepresented in genome sequencing studies, but the NIH, private clinics, and 23andMe and other companies are trying to fix that.

Scientists are working to maximize the benefits and minimize the costs of sharing.

The college has opened an investigation into Michael Deem’s involvement.

Genetics pioneer Craig Venter is not named as a defendant, but the company he founded alleges that he stole trade secrets.

The University of California, Irvine, which found him guilty of inappropriate behavior, will remove Ayala’s name from buildings and scholarships.

University ponders how to replace director of its ancient DNA lab, who quit under a cloud.